SCHEMBL2383575

SCHEMBL2383575

CCCCCS(=O)(=O)OCCC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 12/20 0.46
CA1 P00915 11/20 0.46
CA9 Q16790 8/20 0.46
CA12 O43570 3/20 0.45
CA7 P43166 3/20 0.45
CA14 Q9ULX7 3/20 0.45
CA3 P07451 2/20 0.45
CA4 P22748 2/20 0.45
CA6 P23280 2/20 0.45
CA5A P35218 2/20 0.45
CA5B Q9Y2D0 2/20 0.45
FAAH O00519 3/20 0.44
RECQL P46063 2/20 0.43
GLA P06280 1/20 0.43
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
EPHX2 P34913 1/20 0.43
BLM P54132 1/20 0.43
PRKCA P17252 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25206822 0.98 CA2 (0.48) CA2CA1CA9CA12CA7
SCHEMBL28021552 0.98 CA2 (0.48) CA2CA1CA9CA12CA7
SCHEMBL7871121 0.98 CA2 (0.48) CA2CA1CA9CA12CA7
SCHEMBL6745890 0.98 CA2 (0.48) CA2CA1CA9CA12CA7
SCHEMBL2384852 0.98 CA2 (0.48) CA2CA1CA9CA12CA7
Ammonia Solution, Strong SCHEMBL28064092 0.96 CA2 (0.47) CA2CA1CA9CA12CA7
SCHEMBL28267616 0.96 CA2 (0.47) CA2CA1CA9CA12CA7
SCHEMBL23965433 0.93 CA1 (0.48) CA2CA1CA9CA12CA7
SCHEMBL3802854 0.91 CA2 (0.58) CA2CA1CA9CA12CA7
SCHEMBL6204495 0.91 CA2 (0.54) CA2CA1CA9CA12CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103911615-B Etching agent composite for copper-containing metal 东友精细化工有限公司 2017-08-22 CN claimed
WO-2023122637-A1 METHOD FOR CONTROLLING VOLATILE FATTY ACID CONTENT IN PULP SOLENIS TECHNOLOGIES CAYMAN, L.P. (CH) 2023-06-29 WO disclosed
US-20230193562-A1 METHOD FOR CONTROLLING VOLATILE FATTY ACID CONTENT IN PULP, PAPER, AND/OR BOARD MAKING PROCESSES SOLENIS TECHNOLOGIES, L.P. (US) 2023-06-22 US disclosed
US-10899639-B2 Composition and method for inhibiting microbial adhesion on surfaces SOLENIS TECHNOLOGIES, L.P. (US) 2021-01-26 US disclosed
EP-3691451-A1 COMPOSITION AND METHOD FOR INHIBITING MICROBIAL ADHESION ON SURFACES Solenis Technologies, L.P. (US) 2020-08-12 EP disclosed
WO-2019070868-A1 COMPOSITION AND METHOD FOR INHIBITING MICROBIAL ADHESION ON SURFACES SOLENIS TECHNOLOGIES, L.P. (US) 2019-04-11 WO disclosed
US-20190100447-A1 COMPOSITION AND METHOD FOR INHIBITING MICROBIAL ADHESION ON SURFACES SOLENIS TECHNOLOGIES, L.P. (US) 2019-04-04 US disclosed
CN-103911615-B Etching agent composite for copper-containing metal 东友精细化工有限公司 2017-08-22 CN disclosed
US-8852818-B2 Non-aqueous secondary battery HITACHI MAXELL, LTD. (JP) 2014-10-07 US disclosed
US-20130078509-A1 NON-AQUEOUS SECONDARY BATTERY HITACHI MAXELL ENERGY, LTD. (JP) 2013-03-28 US disclosed
US-20110236737-A1 NON-AQUEOUS SECONDARY BATTERY MAXELL, LTD. (JP) 2011-09-29 US disclosed
US-7829226-B2 positive electrode contains layered structure lithium composite oxide, or spinel thereof containing manganese as active material; non-aqueous electrolytic solution contains additive such as sulfonic acid anhydride, sulfonate ester, cyclic sulfate and cyclic sulfonate ester, and vinylene carbonate HITACHI MAXELL, LTD. (JP) 2010-11-09 US disclosed
US-20100221615-A1 NON-AQUEOUS SECONDARY BATTERY ZHAO JINBAO 2010-09-02 US disclosed
US-20060286459-A1 positive electrode contains layered structure lithium composite oxide, or spinel thereof containing manganese as active material; non-aqueous electrolytic solution contains additive such as sulfonic acid anhydride, sulfonate ester, cyclic sulfate and cyclic sulfonate ester, and vinylene carbonate HITACHI MAXELL, LTD. (JP) 2006-12-21 US disclosed
US-5032523-A Preparation of optically active esters LION CORPORATION (JP) 1991-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190100447-A1 COMPOSITION AND METHOD FOR INHIBITING MICROBIAL ADHESION ON SURFACES DSG1, DSP, EPCAM CA2 1618/4885CA1 1750/4885CA9 1464/4885
US-10899639-B2 Composition and method for inhibiting microbial adhesion on surfaces DSG1, DSP, EPCAM CA2 1618/4885CA1 1750/4885CA9 1464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.